Financhill
Back

Amedisys 10K Form

Buy
52

AMED
Amedisys

Last Price:
89.96
Seasonality Move:
12.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive AMED News And Ratings

See the #1 stock for the next 7 days that we like better than AMED

AMED Financial Statistics

Sales & Book Value

Annual Sales: $2.24B
Cash Flow: $104.03M
Price / Cash Flow: 14.48
Annual Sales: $35.05
Price / Book: 2.55

Profitability

EPS (TTM): 2.52000
Net Income (TTM): $82.93M
Gross Margin: $990.87M
Return on Equity: 7.23%
Return on Assets: 3.97%

Amedisys Earnings Forecast

Key Amedisys Financial Ratios

  • The Gross Profit Margin over the past 31 years for AMED is 44.31%.
  • The Selling, General & Administrative Expenses for AMED have been equal to 34.88% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -320.86% of Operating Income.
  • The Net Earning history of AMED is -0.44% of Total Revenues.
  • Per Share Earnings over the last 31 years have been positive in 17 years.

Amedisys Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: AMED
CUSIP: 023436
Website: amedisys.com

Debt

Debt-to-Equity Ratio: 0.33
Current Ratio: 1.19
Quick Ratio: 1.12

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 18.03

AMED Technical Analysis vs Fundamental Analysis

Buy
52
Amedisys (AMED) is a Buy

Is Amedisys a Buy or a Sell?

  • Amedisys stock is rated a Buy
    The current Amedisys [AMED] share price is $90.00. The Score for AMED is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.